IMMUNITASBIO PRIVATE LIMITED

In their own words

ΙmmunitasBio Pvt. Ltd. is a Bangalore-based biotechnology startup offering novel services and products for accelerating preventive and therapeutic immunological solutions. It is a niche biotech company delivering advanced, bespoke solutions across immune-oncology, vaccine immunology, cell and gene therapy, allergy, and FMCG sectors. With a diverse range of business verticals including bio-services, biobanking, immunodiagnostic products, and cell and gene therapy research, ImmunitasBio has positioned itself as a versatile player in the market. Leveraging its expertise, ImmunitasBio has successfully collaborated with major organizations for bio-services, offering unparalleled value in biologics such as vaccines and immunotherapy, as well as the FMCG sector.The company was heavily involved in assessing Made-In-India COVID-19 vaccine induced immunity in collaboration with major Indian vaccine manufacturers. The company is also advancing a novel in vivo cell and gene therapy platform with a specific focus on solid tumors. ImmunitasBio’s recent infrastructure expansion, including cutting-edge imaging and 3D culture systems, underscores its commitment to precision and personalized medicine.The founder & CEO, Dr. Shiv Baalasubramanian, has spearheaded the development of innovative platforms to evaluate vaccine-induced T and B cell immunity—capabilities essential for gauging efficacy and optimizing booster strategies. His team is also recognized for pioneering rapid, low-volume blood-based T cell immunity kits that are now adopted by leading vaccine manufacturers and global biotechs. The company has been awarded the BIRAC BIG grant from the Govt of India and the ELEVATE grant from the Govt of Karnataka. The company has also won the Govt of Karnataka Star StartUp Award in 2023 and represented India as one of its best deep tech companies at the World Investment Conference in 2024.

Written by the company on its public Startup India profile. Not verified by us.